Fate Therapeutics, Inc. - Common Stock —— 现金流量表 (NASDAQ:FATE) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -39.23 M-162.87 M-248.21 M-132.26 M-122.87 M-106.08 M -103.1 M 投资活动产生的现金 -161.08 M-324.02 M166.75 M112.67 M12.22 M111.17 M 92.08 M 融资活动产生的现金 282.84 M453.13 M9.21 M85 K99.89 M5.49 M — 自由现金流 -39.23 M-162.87 M-248.21 M-132.26 M-122.87 M-112.04 M -108.09 M

新闻

Wall Street Lunch: BP Slips After Ousting Chairman Albert Manifold Over Governance Concern

5 Healthcare Stocks Set to Join the Russell 3000 - TipRanks.com

Fate Therapeutics (FATE) Reports Q1 Loss, Misses Revenue Estimates

CAMP4 Therapeutics Corporation (CAMP) Reports Q1 Loss, Lags Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates

Fate Therapeutics在Leerink全球医疗保健会议上的战略重心转移

Fate Therapeutics at Leerink Global Healthcare Conference: Strategic Shift in Focus

Baird重申Fate Therapeutics股票评级,关注试验进展

Baird reiterates Fate Therapeutics stock rating on trial progress

Fate Therapeutics (FATE) Reports Q4 Loss, Misses Revenue Estimates

Fate TherapeuticsQ4每股收益及营收超出预期